Epstein Secrets

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

m back to school. Pence "said the risk to children of getting COVID-I9 is low while there are `real costs' to students not being in the classroom." McClatchy <https://www.mcclatchydc.corn/news/politics- govemment/article244370917.html#cardLink=row2_card3> (7/21, Schechter, 19K) says Pence described the ra

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

ps://www.bloomberg.corn/news/articles/2020-07-30/changing-the-election-date- would-be-difficult-even-for-congress?srnd=premium> (7/30, Korte, 4.73M), McClatchy <https://www.mcclatchydc.com/news/nation-world/national/article244595962.html#cardLink=row2_cardl> (7/30, Jasper, 19K), the Washington Times <https

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

/30, Datoc, 716K) headlines its report "'No Way' - Top Republicans Kill Trump's Hopes For A Delayed 2020 Election." Bloomberg (7/30, Korte, 4.73M), McClatchy (7/30, Jasper, 19K), the Washington Times (7/30, Boyer, 492K), and CQ Roll Call (7/30, Ruger, 154K) are among the other sources with coverage. Pomp

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

m back to school. Pence "said the risk to children of getting COVID-19 is low while there are 'real costs' to students not being in the classroom." McClatchy (7/21, Schechter, 19K) says Pence described the raise in COVID-19 cases in South Carolina as "serious" but he "sided with Gov. Henry McMaster [R] on

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

m back to school. Pence "said the risk to children of getting COVID-19 is low while there are 'real costs' to students not being in the classroom." McClatchy (7/21, Schechter, 19K) says Pence described the raise in COVID-19 cases in South Carolina as "serious" but he "sided with Gov. Henry McMaster (R) on

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

/30, Datoc, 716K) headlines its report "'No Way' - Top Republicans Kill Trump's Hopes For A Delayed 2020 Election." Bloomberg (7/30, Korte, 4.73M), McClatchy (7/30, Jasper, 19K), the Washington Times (7/30, Boyer, 492K), and CQ Roll Call (7/30, Ruger, 154K) are among the other sources with coverage. Pomp